Prevalence of Potentially Inappropriate Prescriptions According to the New STOPP/START Criteria in Nursing Homes: A Systematic Review

dc.contributor.authorDíaz Planelles, Isabel
dc.contributor.authorNavarro Tapia, Elisabet
dc.contributor.authorGarcía Algar, Óscar
dc.contributor.authorAndreu Fernández, Vicente
dc.date.accessioned2024-06-18T19:13:38Z
dc.date.available2024-06-18T19:13:38Z
dc.date.issued2023-02-01
dc.date.updated2024-06-18T19:13:43Z
dc.description.abstractThe demand for long-term care is expected to increase due to the rising life expectancy and the increased prevalence of long-term illnesses. Nursing home residents are at an increased risk of suffering adverse drug events due to inadequate prescriptions. The main objective of this systematic review is to collect and analyze the prevalence of potentially inadequate prescriptions based on the new version of STOPP/START criteria in this specific population. Databases (PubMed, Web of Science and Cochrane) were searched for inappropriate prescription use in nursing homes according to the second version of STOPP/START criteria. The risk of bias was assessed with the STROBE checklist. A total of 35 articles were assessed for eligibility. One hundred and forty nursing homes and more than 6900 residents were evaluated through the analysis of 13 studies of the last eight years. The reviewed literature returned prevalence ranges between 67.8% and 87.7% according to the STOPP criteria, according to START criteria prevalence ranged from 39.5% to 99.7%. The main factors associated with the presence of inappropriate prescriptions were age, comorbidities, and polypharmacy. These data highlight that, although the STOPP/START criteria were initially developed for community-dwelling older adults, its use in nursing homes may be a starting point to help detect more efficiently inappropriate prescriptions in institutionalized patients. We hope that this review will help to draw attention to the need for medication monitoring systems in this vulnerable population.
dc.format.extent25 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec748418
dc.identifier.issn2227-9032
dc.identifier.pmid36766997
dc.identifier.urihttps://hdl.handle.net/2445/213387
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/healthcare11030422
dc.relation.ispartofHealthcare, 2023, vol. 11, num.3, p. 422
dc.relation.urihttps://doi.org/10.3390/healthcare11030422
dc.rightscc-by (c) Díaz Planelles, I. et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
dc.subject.classificationEfectes secundaris dels medicaments
dc.subject.classificationResidències de persones grans
dc.subject.classificationPrescripció de medicaments
dc.subject.classificationMorbiditat
dc.subject.classificationComorbiditat
dc.subject.otherDrug side effects
dc.subject.otherOld age homes
dc.subject.otherDrug prescribing
dc.subject.otherMorbidity
dc.subject.otherComorbidity
dc.titlePrevalence of Potentially Inappropriate Prescriptions According to the New STOPP/START Criteria in Nursing Homes: A Systematic Review
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
860585.pdf
Mida:
565.81 KB
Format:
Adobe Portable Document Format